Skip to main content

Table 1 Most frequently prescribed potentially inappropriate medication from the EU(7)-PIM and AT-PIM list (described by ATC code and name of the substance) together with the number of filled prescriptions between 2008 and 2011, patients’ median (IQR) age at the time of filling the prescription and number (%) of different patients filling the prescription

From: Utilization of potentially inappropriate medication and risk of adverse drug events among older adults with chronic renal insufficiency: a population-wide cohort study

ATC code

Substance

PIM list

ADE, increased risk of

Prescriptions, n

Patients’ age (years), median (IQR)

Patients, n (%)

A02BC02

Pantoprazole

EU(7)

- C. difficile infection

- hip fracture

107,233

79 (74–84)

6.947 (60.2)

A02BC03

Lansoprazole

EU(7)

- C. difficile infection

- hip fracture

47,291

80 (75–85)

3.238 (28.0)

N06DX02

Ginkgo biloba

EU(7), AT

- orthostatic hypotension and fall

31,395

81 (77–86)

2.266 (19.6)

N02AX02

Tramadol

EU(7), AT

- CNS side effects

28,130

78 (74–84)

4.115 (35.6)

M01AB05

Diclofenac

EU(7), AT

- GI bleeding, ulceration, or perforation

23,001

78 (73–83)

4.399 (38.1)

A02BC01

Omeprazole

EU(7)

- C. difficile infection

- hip fracture

21,601

79 (74–85)

1.657 (14.3)

A02BC05

Esomeprazole

EU(7)

- C. difficile infection

- hip fracture

20,821

79 (74–84)

1.682 (14.6)

C02CA04

Doxazosin

EU(7)

- orthostatic hypotension

- dry mouth

- urinary incontinence/ impaired micturition

- CNS side effects

18,704

77 (73–82)

1.133 (9.8)

C04AD03

Pentoxifyllin

EU(7), AT

- orthostatic hypotension and fall

12,658

80 (76–85)

1.065 (9.2)

C02AC06

Rilmenidine

EU(7)

- orthostatic hypotension

- bradycardia

- CNS side effects

12,241

78 (73–83)

919 (8.0)

  1. ATC code Anatomical Therapeutic Chemical Classification System, IQR Interquartile range